Lactobacillus for preventing recurrent urinary tract infections in women: Meta-analysis

McMaster University, Hamilton, Ontario, Canada.
The Canadian Journal of Urology (Impact Factor: 0.98). 02/2013; 20(1):6607-14.
Source: PubMed


Urinary tract infections (UTIs) are the most common infections affecting women, and often recur. Lactobacillus probiotics could potentially replace low dose, long term antibiotics as a safer prophylactic for recurrent UTI (rUTI). This systematic review and meta-analysis was performed to compile the results of existing randomized clinical trials (RCTs) to determine the efficacy of probiotic Lactobacillus species in preventing rUTI.
MEDLINE and EMBASE were searched from inception to July 2012 for RCTs using a Lactobacillus prophylactic against rUTI in premenopausal adult women. A random-effects model meta-analysis was performed using a pooled risk ratio, comparing incidence of rUTI in patients receiving Lactobacillus to control.
Data from 294 patients across five studies were included. There was no statistically significant difference in the risk for rUTI in patients receiving Lactobacillus versus controls, as indicated by the pooled risk ratio of 0.85 (95% confidence interval of 0.58-1.25, p = 0.41). A sensitivity analysis was performed, excluding studies using ineffective strains and studies testing for safety. Data from 127 patients in two studies were included. A statistically significant decrease in rUTI was found in patients given Lactobacillus, denoted by the pooled risk ratio of 0.51 (95% confidence interval 0.26-0.99, p = 0.05) with no statistical heterogeneity (I2 = 0%).
Probiotic strains of Lactobacillus are safe and effective in preventing rUTI in adult women. However, more RCTs are required before a definitive recommendation can be made since the patient population contributing data to this meta-analysis was small.

Download full-text


Available from: Alison Fox-Robichaud, Dec 27, 2013
  • Source
    • "Orally consumed probiotics ascend to the vaginal tract after they are excreted from the rectum; vaginal administration allows for direct replacement of the probiotics for unhealthy vaginal microbiota and consequently results in maintenance of a low pH and production of antimicrobial substances like acids and hydrogen peroxide. Data from 127 patients in two studies showed a statistically significant decrease in recurrence of bacterial vaginosis in patients given Lactobacillus [26] [27]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Gastrointestinal microbes play important roles in the health and disease of the host. There are many documented evidences which demonstrated that disturbance of intestinal microbiota is linked to the risk of developing infectious, inflammatory and allergic diseases. Human intestine is home for a complex consortium of 1013-1014 microbial cells. Interactions between the intestinal microbes, pathogens and the host lead to exclusion of toxins (mycotoxins) and pathogens (colonization resistance), interference in disease progression as demonstrated in the prevention of oral infection, dental caries, diarrhoeas (Antibiotic Associated Diarrhoea, Travellers’ Diarrhoea and Rotavirus Diarrhoea), postoperative infection, respiratory infection and certain cancers. The group of beneficial intestinal microbes termed probiotics alter intestinal epithelial cell tight junction and immunological functions. Lately, laboratory and clinical studies demonstrated gut-brain axis communication and intestinal microbial (both pathogens and probiotics) modulation of host psycho-neuroimmunological functions, in relation to depression, anxiety and memory dysfunction. These open up many possibilities of probiotics supplementation for moderating intestinal microbiota as an approach in disease prevention and treatment.
    06/2014; 3(2). DOI:10.1016/j.fshw.2014.06.001
  • [Show abstract] [Hide abstract]
    ABSTRACT: To examine whether there is any association between serum levels of 25-hydroxy vitamin D (25(OH) vitamin D) and the recurrence of urinary tract infections (UTIs) among premenopausal women. During a period of 3 years, 93 premenopausal women with a medical history of recurrent UTIs were enrolled from the Infectious Diseases Unit. Cases with recurrent UTIs were compared to 93 age-matched (±5 years) women with no history of recurrent UTI (control group), in terms of serum 25(OH) vitamin D and different risk factors for recurrent UTI. Recurrent UTI was defined as three or more episodes of UTI over a 12-month period. The mean age of women with recurrent UTIs was 43.8±9 years and of controls was 39±10 years (p=0.839). The mean serum levels of 25(OH) vitamin D among women with recurrent UTIs were significantly lower than those of controls (9.8 ng/ml ± 4 vs. 23 ng/ml ± 6; p<0.001). Multivariate analysis showed that a serum 25(OH) vitamin D level of <15 ng/ml (odds ratio 4.00, 95% confidence interval 3.40-4.62; p=0.001) was associated with recurrent UTIs in premenopausal women. In this retrospective study, we found that recurrent UTIs in premenopausal women are associated with vitamin D deficiency.
    International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 08/2013; 17(12). DOI:10.1016/j.ijid.2013.06.007 · 1.86 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Bacterial vaginosis (BV) is traditionally diagnosed using vaginal samples. The aim of this study was to investigate whether BV can be diagnosed from first-void urine (FVU). Self-collected vaginal smears, vaginal swabs, and FVU were obtained from 176 women. BV was diagnosed by Nugent's criteria. The FVU and vaginal swabs were analyzed by quantitative PCRs (qPCRs) for selected vaginal bacteria (Atopobium vaginae, Prevotella spp., Gardnerella vaginalis, bacterial vaginosis-associated bacterium 2, Eggerthella-like bacterium, “Leptotrichia amnionii,” Megasphaera type 1), and all had an area under the receiver operating characteristic (ROC) curve of >85%, suggesting good prediction of BV according to the Nugent score. All seven bacteria in FVU were significantly associated with BV in univariate analysis. An accurate diagnosis of BV from urine was obtained in this population by a combination of qPCRs for Megasphaera type 1 and Prevotella spp. The same two bacteria remained significantly associated with BV in a multivariate model after adjusting for the other five species. There was no statistically significant difference between the sensitivities and specificities of BV diagnosis by molecular methods performed on swabs and FVU samples. A linear regression analysis showed good agreement between bacterial loads from swabs and FVU, but Prevotella spp. could be detected in high numbers in a few FVU samples without being present in swabs. This method will allow diagnosis of BV in studies where only urine has been collected and where detection of BV is considered relevant.
    Journal of clinical microbiology 11/2013; 52(1). DOI:10.1128/JCM.02347-13 · 3.99 Impact Factor
Show more